Literature DB >> 15527683

Myocardial metabolism: a new target for the treatment of heart disease?

Heinrich Taegtmeyer, Rebecca Salazar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15527683     DOI： 10.1007/s11906-004-0033-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  5 in total

1.  Switching metabolic genes to build a better heart.

Authors:  Heinrich Taegtmeyer
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

Review 2.  Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure.

Authors:  E J Eichhorn; M R Bristow
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

Review 3.  Energy metabolism of the heart: from basic concepts to clinical applications.

Authors:  H Taegtmeyer
Journal:  Curr Probl Cardiol       Date:  1994-02       Impact factor: 5.200

4.  Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure.

Authors:  T R Wallhaus; M Taylor; T R DeGrado; D C Russell; P Stanko; R J Nickles; C K Stone
Journal:  Circulation       Date:  2001-05-22       Impact factor: 29.690

5.  The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.

Authors:  Mark A Suckow; Linda S Gutierrez; Christina A Risatti; William R Wolter; Richard E Taylor; Morris Pollard; Rudolph M Navari; Francis J Castellino; Nicholas F Paoni
Journal:  Cancer Lett       Date:  2004-06-25       Impact factor: 8.679
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.